Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study

Edward P.K. Parker, Thomas Hartney, Linda Nab, Gayatri Amirthalingam, Nick Andrews, Eleanor V.H. Barry, Ian J. Douglas, Kathryn E. Mansfield, Anne Suffel, Meredith Leston, OpenSAFELY Collaborative, Brian MacKenna, William J. Hulme, Laurie A. Tomlinson · 2026

Read Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study by Edward P.K. Parker, Thomas Hartney, Linda Nab, Gayatri Amirthalingam, Nick Andrews, Eleanor V.H. Barry, Ian J. Douglas, Kathryn E. Mansfield, Anne Suffel, Meredith Leston, OpenSAFELY Collaborative, Brian MacKenna, William J. Hulme, Laurie A. Tomlinson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13324492.txt.

Description

Edward P.K. Parker and the OpenSAFELY team track severe COVID-19 in immunocompromised adults in England in a 2026 cohort study. People with weak immune systems face high risk, yet few studies focus on them alone.

Each virus wave from 2020 to 2024 held between 475,360 and 508,545 people in five groups, from transplant recipients to those on immune-suppressing drugs. Transplant, bone marrow, and active cancer treatment groups had the highest severe illness rates. Recent vaccination cut risk in every group and wave, though the gain was smallest after transplant, with a hazard ratio of 0.88 in the JN.1 wave. Older age and more health conditions raised risk throughout.

Catalog record

CREATOREdward P.K. Parker, Thomas Hartney, Linda Nab, Gayatri Amirthalingam, Nick Andrews, Eleanor V.H. Barry, Ian J. Douglas, Kathryn E. Mansfield, Anne Suffel, Meredith Leston, OpenSAFELY Collaborative, Brian MacKenna, William J. Hulme, Laurie A. Tomlinson
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47216
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13324492

Browse the full library · About the Tower of Babel